Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al.

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al.

2017 European Association for the Study of the Liver. (2019)

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al.

English English
PDF PDF
Coffee has anti-inflammatory and hepatoprotective properties but its effect on mortality risk has never been investigated in patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). This study shows that elevated coffee consumption (≥3 cups/day) halves all-cause mortality risk in patients co-infected with HIV-HCV. The benefits of coffee extracts and supplementing dietary intake with other anti-inflammatory compounds need to be evaluated in this population.
The selected activity requires you to open a PDF document from an external website.
Click the button below to open the requested document in a new browser tab or window.
To return to this page, switch back to this browser tab, or close the newly opened page.
Open "Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Maria P. Carrieri, et al."
In partnership with:
ISFF
FUAS
Correlation Network